Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies.
Saved in:
| Title: | Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies. |
|---|---|
| Authors: | Senna M; Lahey Hospital and Medical Center, Burlington, MA, USA., Soung J; Southern California Dermatology, Inc, Santa Ana, CA, USA.; Harbor - University of California, Los Angeles, Torrance, CA, USA., Figueras I; Bellvitge Hospital, University of Barcelona, Barcelona, Spain., King B; Dermatology Physicians of Connecticut, Fairfield, CT, USA., Kinoshita-Ise M; Department of Dermatology, Kyorin University School of Medicine, Shinkawa, Mitaka, Tokyo, Japan., Hanna S; University of Toronto, Toronto, ON, Canada., Wu W; Huashan Hospital, Fudan University, Shanghai, China., Wajsbrot D; Pfizer Inc, Groton, CT, USA., Woodworth D; Pfizer Inc, Collegeville, PA, USA., Wolk R; Pfizer Inc, Groton, CT, USA., Chaudhry A; Pfizer Inc, Collegeville, PA, USA., Lejeune A; Pfizer Inc, Paris, France., Tran H; Pfizer Inc, New York, NY, USA. Helen.Tran@pfizer.com. |
| Source: | American journal of clinical dermatology [Am J Clin Dermatol] 2026 Mar 31. Date of Electronic Publication: 2026 Mar 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41917311 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Senna+M%22">Senna M</searchLink>; Lahey Hospital and Medical Center, Burlington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Soung+J%22">Soung J</searchLink>; Southern California Dermatology, Inc, Santa Ana, CA, USA.; Harbor - University of California, Los Angeles, Torrance, CA, USA.<br /><searchLink fieldCode="AU" term="%22Figueras+I%22">Figueras I</searchLink>; Bellvitge Hospital, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22King+B%22">King B</searchLink>; Dermatology Physicians of Connecticut, Fairfield, CT, USA.<br /><searchLink fieldCode="AU" term="%22Kinoshita-Ise+M%22">Kinoshita-Ise M</searchLink>; Department of Dermatology, Kyorin University School of Medicine, Shinkawa, Mitaka, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hanna+S%22">Hanna S</searchLink>; University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Wu+W%22">Wu W</searchLink>; Huashan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wajsbrot+D%22">Wajsbrot D</searchLink>; Pfizer Inc, Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Woodworth+D%22">Woodworth D</searchLink>; Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Wolk+R%22">Wolk R</searchLink>; Pfizer Inc, Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Chaudhry+A%22">Chaudhry A</searchLink>; Pfizer Inc, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lejeune+A%22">Lejeune A</searchLink>; Pfizer Inc, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tran+H%22">Tran H</searchLink>; Pfizer Inc, New York, NY, USA. Helen.Tran@pfizer.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100895290%22">American journal of clinical dermatology</searchLink> [Am J Clin Dermatol] 2026 Mar 31. <i>Date of Electronic Publication: </i>2026 Mar 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100895290 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1888 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211750561%22">11750561 </searchLink><i>NLM ISO Abbreviation: </i>Am J Clin Dermatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41917311 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40257-026-01029-y Languages: – Code: eng Text: English Titles: – TitleFull: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Senna M – PersonEntity: Name: NameFull: Soung J – PersonEntity: Name: NameFull: Figueras I – PersonEntity: Name: NameFull: King B – PersonEntity: Name: NameFull: Kinoshita-Ise M – PersonEntity: Name: NameFull: Hanna S – PersonEntity: Name: NameFull: Wu W – PersonEntity: Name: NameFull: Wajsbrot D – PersonEntity: Name: NameFull: Woodworth D – PersonEntity: Name: NameFull: Wolk R – PersonEntity: Name: NameFull: Chaudhry A – PersonEntity: Name: NameFull: Lejeune A – PersonEntity: Name: NameFull: Tran H IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 03 Text: 2026 Mar 31 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-1888 Titles: – TitleFull: American journal of clinical dermatology Type: main |
| ResultId | 1 |
